|
|
|
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses why delivery has always been a challenge for gene editing technologies and why Gene Writing is different when it comes to efficient delivery. |
|
|
|
|
| How FAIR Data Principles Deliver Clinical Success | Article | By Philip Ross, Revvity Signals Software, Inc. | Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being. |
|
|
| The Value And Impact Of Decentralizing An Oncology Trial | Article | MRN - Medical Research Network | Incorporating hybrid delivery and remote technologies in oncology clinical trials helps remove a significant amount of the patient burden, enabling them to participate more comfortably. |
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
By Antony Hitchcock, principal and owner, AGH Bioconsulting | Drug developers might want to consider longer-term approaches to meeting manufacturing and regulatory requirements. |
|
|
|
|
Connect With Cell & Gene: |
|
|
|